» Authors » David A Cabral

David A Cabral

Explore the profile of David A Cabral including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 83
Citations 1443
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao Y, Oliver M, Schnabel A, Wu E, Wang Z, Marino A, et al.
Ann Rheum Dis . 2025 Feb; PMID: 39966038
The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the article will be...
2.
Toor K, Chen A, Cabral D, Mammen C, Bosman E, Shen Y, et al.
Arthritis Rheumatol . 2024 Dec; PMID: 39624015
Objective: We aimed to study the disease course, outcomes, and predictors of outcome in pediatric-onset antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) affecting the kidneys. Methods: Patients eligible for this study...
3.
Gagne S, Sivaraman V, Bosman E, Klamer B, Morishita K, Huber A, et al.
Arthritis Care Res (Hoboken) . 2024 Oct; PMID: 39467015
Objective: Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are chronic life-threatening vasculitides requiring substantial immunotherapy. Adult trials identified rituximab (RTX) as an alternative to cyclophosphamide (CYC) for remission induction...
4.
Mann S, Bone J, Bosman E, Cabral D, Morishita K, Brown K
RMD Open . 2024 Jun; 10(2). PMID: 38886004
Objectives: The objective of this study is to evaluate whether anti-neutrophil cytoplasmic antibody (ANCA) seropositivity and antigen specificity at diagnosis have predictive utility in paediatric-onset small vessel vasculitis. Methods: Children...
5.
Akbaba T, Toor K, Mann S, Gibson K, Alfaro G, Balci-Peynircioglu B, et al.
Int J Mol Sci . 2024 Apr; 25(7). PMID: 38612581
Chronic primary systemic vasculitis (PSV) comprises a group of heterogeneous diseases that are broadly classified by affected blood vessel size, clinical traits and the presence (or absence) of anti-neutrophil cytoplasmic...
6.
Nguyen K, Barsalou J, Basodan D, Batthish M, Benseler S, Berard R, et al.
Rheumatology (Oxford) . 2023 Oct; 63(SI2):SI173-SI179. PMID: 37851400
Objective: To assess changes in juvenile idiopathic arthritis (JIA) treatments and outcomes in Canada, comparing 2005-2010 and 2017-2021 inception cohorts. Methods: Patients enrolled within three months of diagnosis in the...
7.
Ma J, Siminoski K, Jaremko J, Koujok K, Matzinger M, Shenouda N, et al.
J Clin Endocrinol Metab . 2023 Oct; 109(3):e1225-e1237. PMID: 37843393
Purpose: In this 6-year study we identified factors associated with spontaneous vertebral body reshaping in glucocorticoid (GC)-treated children with leukemia, rheumatic disorders, and nephrotic syndrome. Methods: Subjects were 79 children...
8.
Turgeon D, Bakowsky V, Baldwin C, Cabral D, Clements-Baker M, Clifford A, et al.
Rheumatology (Oxford) . 2023 Feb; 62(8):2646-2651. PMID: 36805625
Objective: In 2020, the Canadian Vasculitis Research Network (CanVasc) published their updated recommendations for the management of ANCA-associated vasculitides (AAV). The current addendum provides further recommendations regarding the use of...
9.
Bowers S, Ng B, Abdossamadi S, Kariminia A, Cabral D, Cuvelier G, et al.
Transplant Cell Ther . 2023 Feb; 29(5):303.e1-303.e9. PMID: 36804932
Adenosinergic signaling has potent, context-specific effects on immune cells, particularly on the dysregulation of lymphocytes. This in turn may have a role in immune activation and loss of tolerance in...
10.
Gibson K, Drogemoller B, Foell D, Benseler S, Graham J, Hancock R, et al.
Arthritis Rheumatol . 2022 Dec; 75(6):1048-1057. PMID: 36530128
Objective: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare, life-threatening inflammation of blood vessels that can affect both adults and children. Compared to adult-onset disease, AAV is especially rare...